Sutro Biopharma Announces $85.0 Million Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
Sutro Biopharma (STRO) IPO Opens Modestly Higher
September 27, 2018 12:36 PM EDTToday's IPO for Sutro Biopharma, Inc. (NASDAQ: STRO) opened for trading at $15.12 after pricing 5,667,000 shares of its common stock at a price to the public of $15.00 per share.
In addition, the underwriters have been granted a 30-day option to purchase up to an... More



